Name: Surgical Robots Market By Product [Instruments & Accessories, Robotic Systems (Laparoscopy, Orthopedic), Services], Application (Urological Surgery, Orthopedic Surgery), End User (Hospitals, Clinics, Ambulatory Surgery Centers) - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: MD6781
Price: 4950 USD
Availability: InStock

報告摘要

The global surgical robots market is projected to reach USD 27.14 billion by 2030 from USD 13.69 billion in 2025, at a CAGR of 14.7% during the forecast period. The surgical robots market is experiencing strong growth as healthcare providers increasingly adopt robotic-assisted systems to enhance surgical precision, improve patient outcomes, and support minimally invasive procedures. The rising demand for faster recovery, reduced complications, and shorter hospital stays is driving hospitals to invest in robotics across multiple specialties. Continuous technological advancements, such as improved imaging, AI-driven guidance, and more compact robotic platforms, are expanding the clinical applications of robotic surgery. At the same time, the growth of surgeon training programs, supportive reimbursement structures, and increased patient awareness are accelerating adoption. Together, these factors are pushing the market forward and broadening the global footprint of robotic-assisted surgery. “By offering, the instruments & accessories segment held the largest market share in 2024.” The instruments & accessories segment accounts for the largest share of the surgical robots market because these components are required for every robotic procedure, creating steady and recurring demand. While robotic systems are a one-time capital investment, instruments such as staplers, scissors, graspers, energy devices, and other consumables must be replaced after a limited number of uses, ensuring continuous utilization and revenue. Accessories, such as vision tools, ports, and trocars, are also essential for system functionality and require frequent replenishment. As robotic procedure volumes continue to rise and hospitals expand their robotic programs, the consumption of instruments and accessories grows proportionally, making this segment the most significant contributor to overall market revenue. “By end user, the hospitals & clinics segment accounted for the largest market share in 2024.” Hospitals & clinics dominate the surgical robots market because they are the primary locations where surgeries are performed and have the necessary facilities, financial resources, and trained personnel to adopt robotic technologies. These institutions invest in robotics to improve surgical precision, enhance patient outcomes, and streamline clinical workflows. Favorable reimbursement policies for minimally invasive procedures further support their adoption of robotic systems. Additionally, most surgeons undergo robotic training within hospital environments, which increases utilization. With growing patient expectations for advanced, minimally invasive care, hospitals & clinics continue to be the largest and most influential end users in the market. “The US is expected to grow at the highest CAGR during the forecast period.” The US is expected to grow at the highest CAGR within the North American surgical robots market due to its strong focus on adopting advanced medical technologies, rapid expansion of robotic-assisted surgical programs, and continuous investments in hospital infrastructure. The country benefits from a large base of trained surgeons, extensive clinical research activity, and high patient demand for minimally invasive procedures, all of which accelerate the uptake of robotic platforms. Favorable reimbursement policies, a strong presence of leading robotic surgery manufacturers, and ongoing product innovations further support growth. Additionally, the US healthcare system’s emphasis on improving patient outcomes, reducing hospital stays, and enhancing surgical precision continues to drive faster adoption of surgical robots compared to other countries in the region. A breakdown of the primary participants (supply side) for the surgical robots market referred to in this report is provided below: • By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%) • By Designation: C-level Executives (45%), Director-level Executives (35%), and Others (20%) • By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%) Prominent players in the surgical robots market are Intuitive Surgical (US), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), Zimmer Biomet (US), Asensus Surgical (US), Siemens Healthineers (Germany), CMR Surgical (UK), Johnson & Johnson (US), and Renishaw Plc (UK). Research Coverage: The report analyzes the surgical robots market and aims at estimating the market size and future growth potential of this market based on various segments such as offering, application, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall surgical robots market. This report will help stakeholders understand the competitive landscape and gain valuable insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market, providing them with information on key market drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers:  Analysis of key drivers (advantages of robot-assisted surgery, technological advancements, improving reimbursement scenario, increasing adoption of surgical robots, and increasing funding for medical robot research), restraints (high cost of robotic systems), opportunities (increasing penetration of surgical robots in ASCs and growth opportunities in emerging markets), and challenges (surgical errors). • Market Penetration: It includes extensive information on products offered by the major players in the global surgical robots market. The report includes various segments by offering, application, end user, and region. • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global surgical robots market. • Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user, and region. • Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global surgical robots market. • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global surgical robots market.

目錄 Table of Contents

1 INTRODUCTION 26 1.1 STUDY OBJECTIVES 26 1.2 MARKET DEFINITION 26 1.3 STUDY SCOPE 27 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 27 1.3.2 INCLUSIONS & EXCLUSIONS 28 1.3.3 YEARS CONSIDERED 28 1.3.4 CURRENCY CONSIDERED 28 1.4 STAKEHOLDERS 29 1.5 SUMMARY OF CHANGES 29 2 EXECUTIVE SUMMARY 31 2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 31 2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 32 2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 33 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 34 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 35 3 MARKET OVERVIEW 36 3.1 INTRODUCTION 36 3.1.1 DRIVERS 37 3.1.1.1 Advantages of robot-assisted minimally invasive surgeries 37 3.1.1.2 Technological advancements in surgical robots 37 3.1.1.3 Improving reimbursement scenario for surgical robots 38 3.1.1.4 Increasing adoption of surgical robots in modern surgeries 39 3.1.1.5 Increasing funding for medical robot research 39 3.1.2 RESTRAINTS 40 3.1.2.1 High cost of robotic systems 40 3.1.3 OPPORTUNITIES 40 3.1.3.1 Increasing penetration of surgical robots in outpatient settings 40 3.1.3.2 High growth opportunities in emerging economies 41 3.1.4 CHALLENGES 42 3.1.4.1 Rising number of surgical errors in global healthcare systems 42 3.2 UNMET NEEDS & WHITE SPACES 43 3.2.1 UNMET NEEDS IN SURGICAL ROBOTS MARKET 43 3.2.2 WHITE SPACE OPPORTUNITIES 44 3.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 45 3.3.1 INTERCONNECTED MARKETS 45 3.3.2 CROSS-SECTOR OPPORTUNITIES 46 3.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 47 4 INDUSTRY TRENDS 48 4.1 PORTER’S FIVE FORCES ANALYSIS 48 4.1.1 THREAT OF NEW ENTRANTS 49 4.1.2 THREAT OF SUBSTITUTES 49 4.1.3 BARGAINING POWER OF SUPPLIERS 49 4.1.4 BARGAINING POWER OF BUYERS 49 4.1.5 INTENSITY OF COMPETITIVE RIVALRY 49 4.2 MACROECONOMIC OUTLOOK 50 4.2.1 INTRODUCTION 50 4.2.2 GDP TRENDS AND FORECAST 50 4.2.3 TRENDS IN GLOBAL MINIMALLY INVASIVE SURGICAL INSTRUMENTS INDUSTRY 52 4.2.4 TRENDS IN GLOBAL MEDICAL ROBOTS INDUSTRY 52 4.3 SUPPLY CHAIN ANALYSIS 53 4.4 VALUE CHAIN ANALYSIS 54 4.5 ECOSYSTEM ANALYSIS 55 4.6 PRICING ANALYSIS 56 4.6.1 AVERAGE SELLING PRICE OF SURGICAL ROBOTIC APPLICATIONS, BY KEY PLAYER, 2024 56 4.6.2 AVERAGE SELLING PRICE TREND OF SURGICAL ROBOTS, BY REGION, 2022–2024 56 4.7 TRADE DATA ANALYSIS 57 4.7.1 IMPORT DATA FOR HS CODE 901890 57 4.7.2 EXPORT DATA FOR HS CODE 901890 58 4.8 KEY CONFERENCES AND EVENTS, 2025–2026 58 4.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 60 4.10 INVESTMENT AND FUNDING SCENARIO 61 4.11 CASE STUDY ANALYSIS 61 4.11.1 REVOLUTIONISING FUTURE OF SURGERY WITH HIGH-PRECISION ROBOTS 61 4.11.2 HUNJAN HOSPITAL DEPLOYS ORTHOPEDIC SURGICAL ROBOT FOR KNEE REPLACEMENT SURGERY 62 4.11.3 BIONAUT LABS CREATES REMOTE-CONTROLLED MICRO-ROBOTS TO TARGET BRAIN DISEASES 62 4.12 IMPACT OF 2025 US TARIFF ON SURGICAL ROBOTS MARKET 63 4.12.1 KEY TARIFF RATES 64 4.12.2 PRICE IMPACT ANALYSIS 64 4.12.3 IMPACT ON COUNTRY/REGION 65 4.12.3.1 North America 65 4.12.3.1.1 US 65 4.12.3.2 Europe 65 4.12.3.3 Asia Pacific 65 4.12.4 IMPACT ON END-USE INDUSTRIES 65 5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 66 5.1 KEY EMERGING TECHNOLOGIES 66 5.1.1 ROBOTIC ARMS AND INSTRUMENTS 66 5.1.2 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML) 66 5.1.3 TELEPRESENCE 66 5.1.4 5G TECHNOLOGY 66 5.1.5 COMPLEMENTARY TECHNOLOGIES 67 5.1.5.1 Augmented reality (AR) and virtual reality (VR) 67 5.1.5.2 3D printing 67 5.2 TECHNOLOGY/PRODUCT ROADMAP 67 5.2.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 67 5.2.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 68 5.2.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 69 5.3 PATENT ANALYSIS 70 5.4 FUTURE APPLICATIONS OF SURGICAL ROBOTS 71 5.5 IMPACT OF AI/GEN AI ON SURGICAL ROBOTS MARKET 72 5.5.1 TOP USE CASES AND MARKET POTENTIAL 73 5.5.2 BEST PRACTICES IN SURGICAL ROBOTS PROCESSING 73 5.5.3 CASE STUDIES OF AI IMPLEMENTATION 74 5.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 75 5.5.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI 76 6 REGULATORY LANDSCAPE 77 6.1 REGIONAL REGULATIONS AND COMPLIANCE 77 6.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 6.1.2 REGULATORY FRAMEWORK 78 6.1.2.1 North America 78 6.1.2.1.1 US 78 6.1.2.2 Europe 79 6.1.2.3 Asia Pacific 79 6.1.2.3.1 Japan 79 6.1.2.3.2 China 80 6.1.2.3.3 India 80 6.1.3 INDUSTRY STANDARDS 81 6.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 82 7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 83 7.1 DECISION-MAKING PROCESS 83 7.2 KEY STAKEHOLDERS & BUYING EVALUATION CRITERIA 83 7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 83 7.2.2 KEY BUYING CRITERIA 84 7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 85 7.4 UNMET NEEDS FROM END-USE INDUSTRIES 85 7.5 MARKET PROFITABILITY 86 7.5.1 REVENUE POTENTIAL 86 7.5.2 COST DYNAMICS 86 7.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 86 8 SURGICAL ROBOTS MARKET, BY OFFERING 87 8.1 INTRODUCTION 88 8.2 INSTRUMENTS & ACCESSORIES 89 8.2.1 NEED FOR RECURRENT PURCHASE OF INSTRUMENTS & ACCESSORIES TO DRIVE MARKET GROWTH 89 8.3 ROBOTIC SYSTEMS 90 8.3.1 LAPAROSCOPIC ROBOTIC SYSTEMS 92 8.3.1.1 Growing popularity of laparoscopic robotic surgeries to drive market 92 8.3.2 ORTHOPEDIC ROBOTIC SYSTEMS 94 8.3.2.1 Rising number of market players offering orthopedic robots to support market growth 94 8.3.3 NEUROSURGICAL ROBOTIC SYSTEMS 95 8.3.3.1 Better reproducibility, higher accuracy, and greater precision in long, narrow surgical corridors to support market growth 95 8.3.4 OTHER ROBOTIC SYSTEMS 97 8.4 SERVICES 98 8.4.1 ONGOING NEED FOR SERVICE CONTRACTS FOR FUNDAMENTAL OPERATIONS TO PROPEL MARKET GROWTH 98 9 SURGICAL ROBOTS MARKET, BY APPLICATION 99 9.1 INTRODUCTION 100 9.2 GENERAL SURGERY 100 9.2.1 GROWING PREFERENCE FOR ROBOT-ASSISTED GENERAL SURGICAL PROCEDURES TO DRIVE MARKET 100 9.3 GYNECOLOGICAL SURGERY 102 9.3.1 RISING NUMBER OF HYSTERECTOMIES TO INCREASE DEMAND FOR SURGICAL ROBOTS 102 9.4 ORTHOPEDIC SURGERY 103 9.4.1 GROWING PREFERENCE FOR KNEE RECONSTRUCTION PROCEDURES TO SUPPORT MARKET GROWTH 103 9.5 UROLOGICAL SURGERY 105 9.5.1 RISING PREVALENCE OF UROLOGICAL DISEASES TO FUEL DEMAND FOR SURGICAL ROBOTS 105 9.6 NEUROSURGERY 106 9.6.1 INCREASING USE OF ROBOTIC TECHNOLOGIES IN NEUROSURGICAL PROCEDURES TO DRIVE MARKET 106 9.7 MICROSURGERY 108 9.7.1 RISING INTERSECTION OF MINIMALLY INVASIVE SURGERY AND SURGICAL ROBOTS TO SUPPORT MARKET GROWTH 108 9.8 OTOLOGICAL SURGERY 110 9.8.1 RISING PREVALENCE OF EAR-RELATED DISORDERS TO SPUR MARKET GROWTH 110 9.9 OTHER APPLICATIONS 111 10 SURGICAL ROBOTS MARKET, BY END USER 113 10.1 INTRODUCTION 114 10.2 HOSPITALS & CLINICS 114 10.2.1 INCREASING ROBOTIC-ASSISTED SURGERIES TO PROPEL MARKET GROWTH 114 10.3 AMBULATORY SURGERY CENTERS 116 10.3.1 GROWING PATIENT PREFERENCE FOR COST-EFFECTIVE TREATMENTS TO DRIVE MARKET GROWTH 116 11 SURGICAL ROBOTS MARKET, BY REGION 118 11.1 INTRODUCTION 119 11.2 NORTH AMERICA 120 11.2.1 US 123 11.2.1.1 US to dominate North American surgical robots market during study period 123 11.2.2 CANADA 125 11.2.2.1 Increased adoption of surgical robots for gynecological surgeries and cancerous tumor removal to drive market 125 11.3 EUROPE 128 11.3.1 GERMANY 130 11.3.1.1 Favorable healthcare initiatives and large pool of stroke patients to spur market growth 130 11.3.2 UK 132 11.3.2.1 Rising investments in surgical robots to propel market growth 132 11.3.3 FRANCE 134 11.3.3.1 Favorable investments and high demand for surgical robotic systems to boost market growth 134 11.3.4 SPAIN 136 11.3.4.1 Increasing number of robotic-assisted surgical procedures and initiatives to fuel growth 136 11.3.5 ITALY 138 11.3.5.1 Increasing number of robotic surgical procedures to propel market growth 138 11.3.6 REST OF EUROPE 140 11.4 ASIA PACIFIC 143 11.4.1 JAPAN 145 11.4.1.1 Favorable government initiatives to support adoption of surgical robots 145 11.4.2 CHINA 147 11.4.2.1 Favorable government initiatives to boost market growth 147 11.4.3 INDIA 150 11.4.3.1 Rapid developments in healthcare infrastructure to support market growth 150 11.4.4 AUSTRALIA 152 11.4.4.1 Increasing implementation and development of s urgical robotic training programs to fuel market growth 152 11.4.5 SOUTH KOREA 154 11.4.5.1 Increasing installation of surgical robots and growing government investments to ensure steady market growth 154 11.4.6 REST OF ASIA PACIFIC 156 11.5 LATIN AMERICA 158 11.5.1 BRAZIL 160 11.5.1.1 Rising incidence of target diseases and growing healthcare expenditure to drive market 160 11.5.2 MEXICO 162 11.5.2.1 Growing emphasis on surgical robotics in healthcare to support market growth 162 11.5.3 REST OF LATIN AMERICA 164 11.6 MIDDLE EAST & AFRICA 167 11.6.1 GCC COUNTRIES 169 11.6.1.1 Robust healthcare industry and favorable government strategies to drive market 169 11.6.2 REST OF MIDDLE EAST & AFRICA 171 12 COMPETITIVE LANDSCAPE 174 12.1 INTRODUCTION 174 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 174 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SURGICAL ROBOTS MARKET 175 12.3 REVENUE ANALYSIS, 2020–2024 177 12.4 MARKET SHARE ANALYSIS, 2024 177 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 181 12.5.1 STARS 181 12.5.2 EMERGING LEADERS 181 12.5.3 PERVASIVE PLAYERS 181 12.5.4 PARTICIPANTS 181 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 183 12.5.5.1 Company footprint 183 12.5.5.2 Region footprint 184 12.5.5.3 Offering footprint 185 12.5.5.4 Application footprint 186 12.5.5.5 End-user footprint 187 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 188 12.6.1 PROGRESSIVE COMPANIES 188 12.6.2 DYNAMIC COMPANIES 188 12.6.3 STARTING BLOCKS 188 12.6.4 RESPONSIVE COMPANIES 188 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 190 12.6.5.1 Detailed list of key startups/SMEs 190 12.6.5.2 Competitive benchmarking of key startups/SMEs 190 12.7 COMPANY VALUATION & FINANCIAL METRICS 191 12.7.1 FINANCIAL METRICS 191 12.7.2 COMPANY VALUATION 191 12.8 BRAND/PRODUCT COMPARISON 192 12.9 COMPETITIVE SCENARIO 193 12.9.1 PRODUCT/SERVICE LAUNCHES AND APPROVALS 193 12.9.2 DEALS 194 12.9.3 EXPANSIONS 195 13 COMPANY PROFILES 196 13.1 KEY PLAYERS 196 13.1.1 INTUITIVE SURGICAL OPERATIONS, INC. 196 13.1.1.1 Business overview 196 13.1.1.2 Products/Services/Solutions offered 197 13.1.1.3 Recent developments 198 13.1.1.3.1 Product approvals 198 13.1.1.3.2 Deals 199 13.1.1.4 MnM view 200 13.1.1.4.1 Right to win 200 13.1.1.4.2 Strategic choices 200 13.1.1.4.3 Weaknesses & competitive threats 200 13.1.2 STRYKER 201 13.1.2.1 Business overview 201 13.1.2.2 Products/Services/Solutions offered 202 13.1.2.3 Recent developments 203 13.1.2.3.1 Product launches 203 13.1.2.3.2 Deals 203 13.1.2.3.3 Expansions 204 13.1.2.4 MnM view 204 13.1.2.4.1 Right to win 204 13.1.2.4.2 Strategic choices 204 13.1.2.4.3 Weaknesses & competitive threats 204 13.1.3 ZIMMER BIOMET 205 13.1.3.1 Business overview 205 13.1.3.2 Products/Services/Solutions offered 206 13.1.3.3 Recent developments 207 13.1.3.3.1 Product approvals 207 13.1.3.3.2 Deals 207 13.1.3.3.3 Other developments 208 13.1.3.4 MnM view 208 13.1.3.4.1 Right to win 208 13.1.3.4.2 Strategic choices 208 13.1.3.4.3 Weaknesses & competitive threats 208 13.1.4 MEDTRONIC 209 13.1.4.1 Business overview 209 13.1.4.2 Products/Services/Solutions offered 210 13.1.4.3 Recent developments 211 13.1.4.3.1 Product approvals 211 13.1.4.3.2 Deals 211 13.1.4.3.3 Expansions 212 13.1.4.4 MnM view 212 13.1.4.4.1 Right to win 212 13.1.4.4.2 Strategic choices 213 13.1.4.4.3 Weaknesses & competitive threats 213 13.1.5 SMITH+NEPHEW 214 13.1.5.1 Business overview 214 13.1.5.2 Products/Services/Solutions offered 215 13.1.5.3 Recent developments 216 13.1.5.3.1 Product & service launches and enhancements 216 13.1.5.4 MnM view 216 13.1.5.4.1 Right to win 216 13.1.5.4.2 Strategic choices 216 13.1.5.4.3 Weaknesses & competitive threats 217 13.1.6 ASENSUS SURGICAL US, INC. 218 13.1.6.1 Business overview 218 13.1.6.2 Products/Services/Solutions offered 219 13.1.6.3 Recent developments 219 13.1.6.3.1 Product approvals 219 13.1.6.3.2 Deals 220 13.1.7 SIEMENS HEALTHINEERS AG 222 13.1.7.1 Business overview 222 13.1.7.2 Products/Services/Solutions offered 223 13.1.7.3 Recent developments 224 13.1.7.3.1 Deals 224 13.1.8 RENISHAW PLC 225 13.1.8.1 Business overview 225 13.1.8.2 Products/Services/Solutions offered 226 13.1.8.3 Recent developments 227 13.1.8.3.1 Product approvals 227 13.1.9 GLOBUS MEDICAL 228 13.1.9.1 Business overview 228 13.1.9.2 Products/Services/Solutions offered 229 13.1.9.3 Recent developments 230 13.1.9.3.1 Product approvals 230 13.1.10 JOHNSON & JOHNSON 231 13.1.10.1 Business overview 231 13.1.10.2 Products/Services/Solutions offered 232 13.1.10.3 Recent developments 233 13.1.10.3.1 Product approvals 233 13.1.11 CMR SURGICAL LTD. 234 13.1.11.1 Business overview 234 13.1.11.2 Products/Services/Solutions offered 234 13.1.11.3 Recent developments 235 13.1.11.3.1 Product approvals 235 13.1.11.3.2 Deals 235 13.1.11.3.3 Expansions 236 13.1.11.3.4 Other developments 236 13.1.12 THINK SURGICAL, INC. 237 13.1.12.1 Business overview 237 13.1.12.2 Products/Services/Solutions offered 237 13.1.12.3 Recent developments 238 13.1.12.3.1 Product approvals 238 13.1.12.3.2 Deals 238 13.1.13 CORIN GROUP 240 13.1.13.1 Business overview 240 13.1.13.2 Products/Services/Solutions offered 240 13.1.13.3 Recent developments 241 13.1.13.3.1 Product launches & approvals 241 13.1.14 MICROSURE 242 13.1.14.1 Business overview 242 13.1.14.2 Products/Services/Solutions offered 242 13.1.14.3 Recent developments 243 13.1.14.3.1 Other developments 243 13.1.15 AVATERAMEDICAL GMBH 244 13.1.15.1 Business overview 244 13.1.15.2 Products/Services/Solutions offered 244 13.1.16 MEDICAL MICROINSTRUMENTS, INC. 245 13.1.16.1 Business overview 245 13.1.16.2 Products/Services/Solutions offered 245 13.1.16.3 Recent developments 245 13.1.16.3.1 Product approvals 245 13.1.16.3.2 Deals 246 13.1.16.3.3 Other developments 246 13.1.17 MEDICAROID CORPORATION 247 13.1.17.1 Business overview 247 13.1.17.2 Products/Services/Solutions offered 247 13.1.17.3 Recent developments 248 13.1.17.3.1 Product approvals 248 13.1.17.3.2 Deals 248 13.1.18 BRAINLAB SE 249 13.1.18.1 Business overview 249 13.1.18.2 Products/Services/Solutions offered 249 13.1.18.3 Recent developments 250 13.1.18.3.1 Product approvals 250 13.1.18.3.2 Deals 250 13.1.19 ECENTIAL ROBOTICS 251 13.1.19.1 Business overview 251 13.1.19.2 Products/Services/Solutions offered 251 13.1.19.3 Recent developments 252 13.1.19.3.1 Product approvals 252 13.1.19.3.2 Deals 252 13.1.20 SS INNOVATIONS INTERNATIONAL, INC. 253 13.1.20.1 Business overview 253 13.1.20.2 Products/Services/Solutions offered 255 13.1.20.3 Products/Services/Solutions in pipeline 257 13.1.20.4 Recent developments 257 13.1.20.4.1 Product launches and approvals 257 13.1.20.5 MnM view 258 13.1.20.5.1 Right to win 258 13.1.20.5.2 Strategic choices 258 13.1.20.5.3 Weaknesses & competitive threats 258 13.2 OTHER PLAYERS 259 13.2.1 MONTERIS 259 13.2.2 MOMENTIS INNOVATIVE SURGERY 259 13.2.3 TINAVI MEDICAL TECHNOLOGIES CO., LTD. 260 13.2.4 DISTALMOTION SA 261 13.2.5 NOVUS SAĞLIK ÜRÜNLERI AR-GE DANIŞMANLIK (NOVUS ARGE) 262 14 RESEARCH METHODOLOGY 263 14.1 RESEARCH DATA 263 14.1.1 SECONDARY DATA 264 14.1.1.1 Key sources of secondary data 264 14.1.1.2 Key data from secondary sources 265 14.1.2 PRIMARY DATA 265 14.1.2.1 Key objectives of primary research 266 14.1.2.2 Key data from primary sources 266 14.1.2.3 Key industry insights 267 14.2 MARKET SIZE ESTIMATION 267 14.2.1 BOTTOM-UP APPROACH 267 14.2.2 TOP-DOWN APPROACH 268 14.2.3 BASE NUMBER ESTIMATION 268 14.2.3.1 Supply-side analysis (revenue share analysis) 268 14.2.3.2 Company presentations and primary interviews 270 14.3 MARKET FORECAST APPROACH 270 14.4 DATA TRIANGULATION 272 14.5 STUDY ASSUMPTIONS 274 14.5.1 MARKET SHARE ASSUMPTIONS 274 14.5.2 RESEARCH ASSUMPTIONS 274 14.6 FACTOR ANALYSIS 275 14.7 RISK ANALYSIS 275 14.8 RESEARCH LIMITATIONS 276 15 APPENDIX 277 15.1 DISCUSSION GUIDE 277 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 281 15.3 CUSTOMIZATION OPTIONS 283 15.4 RELATED REPORTS 283 15.5 AUTHOR DETAILS 284

圖表清單 List of Tables & Figures

TABLE 1 SURGICAL ROBOTS MARKET: INCLUSIONS & EXCLUSIONS 28 TABLE 2 STANDARD CURRENCY CONVERSION RATES 29 TABLE 3 SURGICAL ROBOTS MARKET: CURRENT UNMET NEEDS 44 TABLE 4 SURGICAL ROBOTS MARKET: PORTER’S FIVE FORCES 48 TABLE 5 GDP PERCENTAGE CHANGE, BY COUNTRY, 2021–2030 50 TABLE 6 AVERAGE SELLING PRICE OF SURGICAL ROBOTIC APPLICATIONS, BY KEY PLAYER, 2024 (USD MILLION) 56 TABLE 7 AVERAGE PRICING TREND OF SURGICAL ROBOTS, BY REGION, 2022–2024 (USD MILLION) 56 TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 57 TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 58 TABLE 10 LIST OF KEY CONFERENCES AND EVENTS IN SURGICAL ROBOTS MARKET, JANUARY 2025–DECEMBER 2026 58 TABLE 11 CASE STUDY 1: REVOLUTIONISING FUTURE OF SURGERY WITH HIGH-PRECISION ROBOTS 61 TABLE 12 CASE STUDY 2: HUNJAN HOSPITAL DEPLOYS ORTHOPEDIC SURGICAL ROBOT FOR KNEE REPLACEMENT SURGERY 62 TABLE 13 CASE STUDY 3: BIONAUT LABS CREATES REMOTE-CONTROLLED MICRO-ROBOTS TO TARGET BRAIN DISEASES 62 TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES 64 TABLE 15 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR SURGICAL ROBOTS 64 TABLE 16 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 17 US FDA: MEDICAL DEVICE CLASSIFICATION 78 TABLE 18 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 78 TABLE 19 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 79 TABLE 20 CHINA: CLASSIFICATION OF MEDICAL DEVICES 80 TABLE 21 GLOBAL STANDARDS IN SURGICAL ROBOTS MARKET 81 TABLE 22 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN SURGICAL ROBOTS MARKET 82 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS 83 TABLE 24 KEY BUYING CRITERIA FOR KEY TWO END USERS 84 TABLE 25 UNMET NEEDS FROM END-USE INDUSTRIES IN SURGICAL ROBOTS MARKET 85 TABLE 26 SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 88 TABLE 27 SURGICAL ROBOTS MARKET, BY REGION, 2023–2030 (MILLION UNITS) 88 TABLE 28 SURGICAL ROBOT INSTRUMENTS & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 90 TABLE 29 SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 91 TABLE 30 SURGICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 31 LAPAROSCOPIC ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 32 ORTHOPEDIC ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 33 NEUROSURGICAL ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 34 OTHER ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 35 SURGICAL ROBOT SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 36 SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 100 TABLE 37 SURGICAL ROBOTS MARKET FOR GENERAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 38 SURGICAL ROBOTS MARKET FOR GYNECOLOGICAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 39 SURGICAL ROBOTS MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 40 SURGICAL ROBOTS MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 41 SURGICAL ROBOTS MARKET FOR NEUROSURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 42 SURGICAL ROBOTS MARKET FOR MICROSURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 43 SURGICAL ROBOTS MARKET FOR OTOLOGICAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 44 SURGICAL ROBOTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 45 SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 114 TABLE 46 SURGICAL ROBOTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 47 SURGICAL ROBOTS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 48 SURGICAL ROBOTS MARKET, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 49 NORTH AMERICA: SURGICAL ROBOTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 50 NORTH AMERICA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 122 TABLE 51 NORTH AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 122 TABLE 52 NORTH AMERICA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 123 TABLE 53 NORTH AMERICA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 123 TABLE 54 US: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 124 TABLE 55 US: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 124 TABLE 56 US: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 125 TABLE 57 US: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 125 TABLE 58 CANADA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 126 TABLE 59 CANADA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 60 CANADA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 127 TABLE 61 CANADA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 127 TABLE 62 EUROPE: SURGICAL ROBOTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 63 EUROPE: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 128 TABLE 64 EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 129 TABLE 65 EUROPE: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 129 TABLE 66 EUROPE: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 129 TABLE 67 GERMANY: SURGICAL ROBOTS MARKET, BY OFFERING, 2 023–2030 (USD MILLION) 131 TABLE 68 GERMANY: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 131 TABLE 69 GERMANY: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 132 TABLE 70 GERMANY: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 132 TABLE 71 UK: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 133 TABLE 72 UK: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 73 UK: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 134 TABLE 74 UK: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 134 TABLE 75 FRANCE: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 135 TABLE 76 FRANCE: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 135 TABLE 77 FRANCE: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 136 TABLE 78 FRANCE: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 136 TABLE 79 SPAIN: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 137 TABLE 80 SPAIN: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 137 TABLE 81 SPAIN: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 138 TABLE 82 SPAIN: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 138 TABLE 83 ITALY: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 139 TABLE 84 ITALY: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 139 TABLE 85 ITALY: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140 TABLE 86 ITALY: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 87 REST OF EUROPE: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 141 TABLE 88 REST OF EUROPE: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 89 REST OF EUROPE: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 142 TABLE 90 REST OF EUROPE: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 142 TABLE 91 ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 92 ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 144 TABLE 93 ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 94 ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 145 TABLE 95 ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 145 TABLE 96 JAPAN: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 146 TABLE 97 JAPAN: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 98 JAPAN: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147 TABLE 99 JAPAN: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 100 CHINA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 148 TABLE 101 CHINA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 102 CHINA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 149 TABLE 103 CHINA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 149 TABLE 104 INDIA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 151 TABLE 105 INDIA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 106 INDIA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 151 TABLE 107 INDIA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 152 TABLE 108 AUSTRALIA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 152 TABLE 109 AUSTRALIA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 110 AUSTRALIA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 153 TABLE 111 AUSTRALIA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 153 TABLE 112 SOUTH KOREA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 154 TABLE 113 SOUTH KOREA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 155 TABLE 114 SOUTH KOREA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 155 TABLE 115 SOUTH KOREA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 156 TABLE 116 REST OF ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 156 TABLE 117 REST OF ASIA PACIFIC: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 157 TABLE 118 REST OF ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 157 TABLE 119 REST OF ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 158 TABLE 120 LATIN AMERICA: SURGICAL ROBOTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 121 LATIN AMERICA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 159 TABLE 122 LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 123 LATIN AMERICA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 160 TABLE 124 LATIN AMERICA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 125 BRAZIL: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 161 TABLE 126 BRAZIL: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 127 BRAZIL: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 162 TABLE 128 BRAZIL: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 162 TABLE 129 MEXICO: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 163 TABLE 130 MEXICO: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 131 MEXICO: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 164 TABLE 132 MEXICO: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 164 TABLE 133 REST OF LATIN AMERICA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 165 TABLE 134 REST OF LATIN AMERICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 135 REST OF LATIN AMERICA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 166 TABLE 136 REST OF LATIN AMERICA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 166 TABLE 137 MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY REGION, 2023–2030 (USD MILLION) 168 TABLE 138 MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 168 TABLE 139 MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 140 MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 169 TABLE 141 MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 142 GCC COUNTRIES: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 170 TABLE 143 GCC COUNTRIES: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 144 GCC COUNTRIES: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 171 TABLE 145 GCC COUNTRIES: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 171 TABLE 146 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 172 TABLE 147 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 148 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 173 TABLE 149 REST OF MIDDLE EAST & AFRICA: SURGICAL ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 150 KEY STRATEGIES DEPLOYED BY MAJOR PLAYERS IN SURGICAL ROBOTS MARKET, JANUARY 2021–DECEMBER 2025 175 TABLE 151 SURGICAL ROBOTS MARKET: DEGREE OF COMPETITION 178 TABLE 152 SURGICAL ROBOTS MARKET: REGION FOOTPRINT 184 TABLE 153 SURGICAL ROBOTS MARKET: OFFERING FOOTPRINT 185 TABLE 154 SURGICAL ROBOTS MARKET: APPLICATION FOOTPRINT 186 TABLE 155 SURGICAL ROBOTS MARKET: END-USER FOOTPRINT 187 TABLE 156 SURGICAL ROBOTS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 190 TABLE 157 SURGICAL ROBOTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY ROBOTIC SYSTEM TYPE AND REGION 190 TABLE 158 SURGICAL ROBOTS MARKET: PRODUCT/SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2025 193 TABLE 159 SURGICAL ROBOTS MARKET: DEALS, JANUARY 2021–DECEMBER 2025 194 TABLE 160 SURGICAL ROBOTS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2025 195 TABLE 161 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY OVERVIEW 196 TABLE 162 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 197 TABLE 163 INTUITIVE SURGICALOPERATIONS, INC.: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 198 TABLE 164 INTUITIVE SURGICAL OPERATIONS, INC.: DEALS, JANUARY 2021–DECEMBER 2025 199 TABLE 165 STRYKER: COMPANY OVERVIEW 201 TABLE 166 STRYKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED 202 TABLE 167 STRYKER: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2025 203 TABLE 168 STRYKER: DEALS, JANUARY 2021–DECEMBER 2025 203 TABLE 169 STRYKER: EXPANSIONS, JANUARY 2021–DECEMBER 2025 204 TABLE 170 ZIMMER BIOMET: COMPANY OVERVIEW 205 TABLE 171 ZIMMER BIOMET: PRODUCTS/SERVICES/SOLUTIONS OFFERED 206 TABLE 172 ZIMMER BIOMET: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 207 TABLE 173 ZIMMER BIOMET: DEALS, JANUARY 2021–DECEMBER 2025 207 TABLE 174 ZIMMER BIOMET: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2025 208 TABLE 175 MEDTRONIC: COMPANY OVERVIEW 209 TABLE 176 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 210 TABLE 177 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 211 TABLE 178 MEDTRONIC: DEALS, JANUARY 2021–DECEMBER 2025 211 TABLE 179 MEDTRONIC: EXPANSIONS, JANUARY 2021–DECEMBER 2025 212 TABLE 180 SMITH+NEPHEW: COMPANY OVERVIEW 214 TABLE 181 SMITH+NEPHEW: PRODUCTS/SERVICES/SOLUTIONS OFFERED 215 TABLE 182 SMITH+NEPHEW: PRODUCT & SERVICE LAUNCHES AND ENHANCEMENTS, JANUARY 2021–DECEMBER 2025 216 TABLE 183 ASENSUS SURGICAL US, INC.: COMPANY OVERVIEW 218 TABLE 184 ASENSUS SURGICAL US, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 219 TABLE 185 ASENSUS SURGICAL US, INC.: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 219 TABLE 186 ASENSUS SURGICAL US, INC.: DEALS, JANUARY 2021–DECEMBER 2025 220 TABLE 187 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 222 TABLE 188 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 223 TABLE 189 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–DECEMBER 2025 224 TABLE 190 RENISHAW PLC: COMPANY OVERVIEW 225 TABLE 191 RENISHAW PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 226 TABLE 192 RENISHAW PLC: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 227 TABLE 193 GLOBUS MEDICAL: COMPANY OVERVIEW 228 TABLE 194 GLOBUS MEDICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 229 TABLE 195 GLOBUS MEDICAL: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 230 TABLE 196 JOHNSON & JOHNSON: COMPANY OVERVIEW 231 TABLE 197 JOHNSON & JOHNSON: PRODUCTS/SERVICES/SOLUTIONS OFFERED 232 TABLE 198 JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 233 TABLE 199 CMR SURGICAL LTD.: COMPANY OVERVIEW 234 TABLE 200 CMR SURGICAL LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 234 TABLE 201 CMR SURGICAL LTD.: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 235 TABLE 202 CMR SURGICAL LTD.: DEALS, JANUARY 2021–DECEMBER 2025 235 TABLE 203 CMR SURGICAL LTD.: EXPANSIONS, JANUARY 2021–DECEMBER 2025 236 TABLE 204 CMR SURGICAL LTD.: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2025 236 TABLE 205 THINK SURGICAL, INC.: COMPANY OVERVIEW 237 TABLE 206 THINK SURGICAL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 237 TABLE 207 THINK SURGICAL, INC.: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 238 TABLE 208 THINK SURGICAL, INC.: DEALS, JANUARY 2021–DECEMBER 2025 238 TABLE 209 CORIN GROUP: COMPANY OVERVIEW 240 TABLE 210 CORIN GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED 240 TABLE 211 CORIN GROUP: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2025 241 TABLE 212 MICROSURE: COMPANY OVERVIEW 242 TABLE 213 MICROSURE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 242 TABLE 214 MICROSURE: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2025 243 TABLE 215 AVATERAMEDICAL GMBH: COMPANY OVERVIEW 244 TABLE 216 AVATERAMEDICAL GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 244 TABLE 217 MEDICAL MICROINSTRUMENTS, INC.: COMPANY OVERVIEW 245 TABLE 218 MEDICAL MICROINSTRUMENTS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 245 TABLE 219 MEDICAL MICROINSTRUMENTS, INC.: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 245 TABLE 220 MEDICAL MICROINSTRUMENTS, INC.: DEALS, JANUARY 2021–DECEMBER 2025 246 TABLE 221 MEDICAL MICROINSTRUMENTS, INC.: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2025 246 TABLE 222 MEDICAROID CORPORATION: COMPANY OVERVIEW 247 TABLE 223 MEDICAROID CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 247 TABLE 224 MEDICAROID CORPORATION: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 248 TABLE 225 MEDICAROID CORPORATION: DEALS, JANUARY 2021–DECEMBER 2025 248 TABLE 226 BRAINLAB SE: COMPANY OVERVIEW 249 TABLE 227 BRAINLAB SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 249 TABLE 228 BRAINLAB SE: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 250 TABLE 229 BRAINLAB SE: DEALS, JANUARY 2021–DECEMBER 2025 250 TABLE 230 ECENTIAL ROBOTICS: COMPANY OVERVIEW 251 TABLE 231 ECENTIAL ROBOTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 251 TABLE 232 ECENTIAL ROBOTICS: PRODUCT APPROVALS, JANUARY 2021–DECEMBER 2025 252 TABLE 233 ECENTIAL ROBOTICS: DEALS, JANUARY 2021–DECEMBER 2025 252 TABLE 234 SS INNOVATIONS INTERNATIONAL, INC.: COMPANY OVERVIEW 254 TABLE 235 SS INNOVATIONS INTERNATIONAL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 255 TABLE 236 SS INNOVATIONS INTERNATIONAL, INC.: PRODUCTS/SERVICES/SOLUTIONS IN PIPELINE 257 TABLE 237 SS INNOVATIONS INTERNATIONAL, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–DECEMBER 2025 257 TABLE 238 MONTERIS: COMPANY OVERVIEW 259 TABLE 239 MOMENTIS INNOVATIVE SURGERY: COMPANY OVERVIEW 259 TABLE 240 TINAVI MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 260 TABLE 241 DISTALMOTION SA: COMPANY OVERVIEW 261 TABLE 242 NOVUS SAĞLIK ÜRÜNLERI AR-GE DANIŞMANLIK (NOVUS ARGE): COMPANY OVERVIEW 262 TABLE 243 SURGICAL ROBOTS MARKET: RESEARCH ASSUMPTIONS 274 TABLE 244 SURGICAL ROBOTS MARKET: RISK ANALYSIS 275 FIGURE 1 SURGICAL ROBOTS MARKET SEGMENTATION & REGIONAL SCOPE 27 FIGURE 2 SURGICAL ROBOTS MARKET: YEARS CONSIDERED 28 FIGURE 3 KEY INSIGHTS & MARKET HIGHLIGHTS 31 FIGURE 4 SURGICAL ROBOTS MARKET, BY OFFERING, 2025–2030 (USD MILLION) 32 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL ROBOTS MARKET 32 FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF SURGICAL ROBOTS MARKET 33 FIGURE 7 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN SURGICAL ROBOTS MARKET (2024) 34 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 35 FIGURE 9 SURGICAL ROBOTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36 FIGURE 10 SURGICAL ROBOTS MARKET: PORTER’S FIVE FORCES ANALYSIS 48 FIGURE 11 SURGICAL ROBOTS MARKET: SUPPLY CHAIN ANALYSIS 53 FIGURE 12 SURGICAL ROBOTS MARKET: VALUE CHAIN ANALYSIS 54 FIGURE 13 SURGICAL ROBOTS MARKET: ECOSYSTEM ANALYSIS 55 FIGURE 14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN SURGICAL ROBOTS MARKET 60 FIGURE 15 INVESTMENT/VENTURE CAPITAL SCENARIO IN SURGICAL ROBOTS MARKET, 2020–2023 (USD BILLION) 61 FIGURE 16 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR SURGICAL ROBOTS MARKET (JANUARY 2015–OCTOBER 2025) 70 FIGURE 17 TOP PATENT APPLICANT COUNTRIES FOR SURGICAL ROBOTS (JANUARY 2014–DECEMBER 2024) 71 FIGURE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS 83 FIGURE 19 KEY BUYING CRITERIA FOR TOP TWO END USERS 84 FIGURE 20 SURGICAL ROBOTS MARKET: GEOGRAPHIC SNAPSHOT 119 FIGURE 21 NORTH AMERICA: SURGICAL ROBOTS MARKET SNAPSHOT 121 FIGURE 22 ASIA PACIFIC: SURGICAL ROBOTS MARKET SNAPSHOT 143 FIGURE 23 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN SURGICAL ROBOTS MARKET (2020−2024) 177 FIGURE 24 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SURGICAL ROBOTS MARKET (2024) 178 FIGURE 25 SURGICAL ROBOTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 182 FIGURE 26 SURGICAL ROBOTS MARKET: COMPANY FOOTPRINT 183 FIGURE 27 SURGICAL ROBOTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 189 FIGURE 28 EV/EBITDA OF KEY VENDORS 191 FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 191 FIGURE 30 SURGICAL ROBOTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 192 FIGURE 31 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY SNAPSHOT 197 FIGURE 32 STRYKER: COMPANY SNAPSHOT 202 FIGURE 33 ZIMMER BIOMET: COMPANY SNAPSHOT 206 FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT 210 FIGURE 35 SMITH+NEPHEW: COMPANY SNAPSHOT 215 FIGURE 36 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 223 FIGURE 37 RENISHAW PLC: COMPANY SNAPSHOT 226 FIGURE 38 GLOBUS MEDICAL: COMPANY SNAPSHOT 229 FIGURE 39 JOHNSON & JOHNSON: COMPANY SNAPSHOT 232 FIGURE 40 SS INNOVATIONS INTERNATIONAL, INC.: COMPANY SNAPSHOT 254 FIGURE 41 SURGICAL ROBOTS MARKET: RESEARCH DESIGN 263 FIGURE 42 SURGICAL ROBOTS MARKET: KEY DATA FROM SECONDARY SOURCES 265 FIGURE 43 SURGICAL ROBOTS MARKET: KEY PRIMARY SOURCES (BY COMPANY TYPE, DESIGNATION, AND REGION) 265 FIGURE 44 SURGICAL ROBOTS MARKET: KEY DATA FROM PRIMARY SOURCES 266 FIGURE 45 SURGICAL ROBOTS MARKET: KEY INDUSTRY INSIGHTS 267 FIGURE 46 SURGICAL ROBOTS MARKET: BOTTOM-UP APPROACH 268 FIGURE 47 SURGICAL ROBOTS MARKET: TOP-DOWN APPROACH 268 FIGURE 48 SUPPLY-SIDE SURGICAL ROBOTS MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 269 FIGURE 49 SURGICAL ROBOTS MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR STRYKER 269 FIGURE 50 SUPPLY-SIDE SURGICAL ROBOTS MARKET ESTIMATION (2024) 270 FIGURE 51 SURGICAL ROBOTS MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS) 271 FIGURE 52 SURGICAL ROBOTS MARKET: DATA TRIANGULATION METHODOLOGY 273 FIGURE 53 SURGICAL ROBOTS MARKET: FACTOR ANALYSIS 275

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Surgical Robots Market By Product [Instruments & Accessories, Robotic Systems (Laparoscopy, Orthopedic), Services], Application (Urological Surgery, Orthopedic Surgery), End User (Hospitals, Clinics, Ambulatory Surgery Centers) - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（醫療器材）